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Extracts of the aerial parts of Salvia chamelaeagnea and L. leonurus were evaluated for the in vitro antibacterial activity when tested in
combination against two Gram-positive bacteria (Bacillus cereus and Staphylococcus aureus) and two Gram-negative bacteria (Escherichia coli
and Klebsiella pneumoniae) using the microdilution method. The minimum inhibitory concentration (MIC) were determined for the individual
plant extract and also in combination using the fractional inhibitory concentration (FIC) and represented as data points in isobolograms.
Individually, the plant extract showed good antibacterial activity against the four pathogens tested with the MIC values ≤3 mg mL−1. When the
two extracts were combined, synergistic actions were observed against the Gram-positive bacteria while antagonism, synergism and/or additive
actions were observed for the various ratios tested on the Gram-negative bacteria.
© 2006 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Salvia chamelaeagnea; Leonotis leonurus; Lamiaceae; Synergy; AntimicrobialThe increasing use of antibiotics andmisuse by over-prescribing
and/or poor patient compliance has led to the development of
bacterial resistance to antibiotics (Kotzé and Eloff, 2002). This
resistance has catalyzed the search for new antibacterial agents. The
use of synergistic combinations in antimicrobial chemotherapy is
often used commercially in the treatment of various infections (e.g.
Augmentin™). Traditional healers often use combinations of plants
to treat or cure diseases (Iwu, 1994). One notable example from the
ethnobotanical literature is the concomitant administration of
various Salvia species with Leonotis leonurus (L.) R. Br. to treat
various infections (Watt andBreyer-Brandwijk, 1962). In this study,
we assessed the antibacterial activity of Salvia chamelaeagnea
Berg. and L. leonurus when used singularly and in combination.
S. chamelaeagnea and L. leonurus were collected from the
West Coast (Cape Province, South Africa) and Johannesburg
respectively and identified at the South African National Biodiver-
sity Institute (Pretoria). Voucher specimens (AV 848 and AV 960)
were deposited in the School of Pharmacy and Pharmacology,⁎ Corresponding author.
E-mail address: viljoenam@tut.ac.za (A.M. Viljoen).
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doi:10.1016/j.sajb.2006.03.011University of the Witwatersrand, South Africa. The aerial parts of
the two plants were air-dried at room temperature, fine-grounded,
extracted with a mixture of methanol/chloroform (1:1) in a water
bath at 40 °C for 3 h, filtered and evaporated.
The stock solution of each plant was made up to at a concen-
tration of 64mgmL−1 with acetone and ten combinations at various
ratios were prepared. The following ratios of S. chamelaeagnea and
L. leonurus were considered respectively: 10:0; 9:1; 8:2; 7:3; 6:4;
5:5, 3:7; 2:8; 1:9 and 0:10. The antibacterial activity was evaluated
against two Gram-positive bacteria Bacillus cereus (ATCC 11778)
and Staphylococcus aureus (ATCC 25923); two Gram-negative
bacteria Klebsiella pneumoniae (NTCC 9633) and Escherichia
coli (ATCC 8739) using the microdilution method (Eloff, 1998).
Briefly, each combination ratio was serially diluted (1:1) with
sterile water in a 96-well microtitre plate and an equal volume
of bacterial suspensions with an approximately inoculum size
of 1×106 CFU mL−1 was added to the wells. The plates were
incubated for 24 h at 37 °C. An aqueous solution of p-iodo-
nitrotetrazolium chloridewas added to thewells and theMIC values
were determined as the concentration preventing visible bacterial
growth after 6 h. The tests were initially performed singularly andts reserved.
Table 1
MIC values of S. chamelaeagnea and L. leonurus against four bacterial pathogens (μg mL−1)
Species/Control Pathogens
E. coli (ATCC 8739) K. pneumoniae (NTCC 9633) S. aureus (ATCC 25923) B. cereus (ATCC 11778)
S. chamelaeagnea 3000.00 3000.00 200.00 300.00
L. leonurus 2000.00 3000.00 2000.00 2000.00
Ciprofloxacin 0.04 0.16 0.31 0.04
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control.
The lowest concentration of the test sample in which no growth
occurred was defined as the minimum inhibitory concentration
(MIC). The interaction of S. chamelaeagnea and L. leonurus ex-
tracts in various ratios was determined algebraically (Eq. (1)) based
on the sum of the fractional inhibitory concentration (Berenbaum,
1978). All ratios were represented graphically by construction of
isobolograms (Canfield et al., 1995) using themean of the triplicate
experiments. The data points for construction of the isobolograms
were obtained for the various ratios by plotting the MICS in
combination/MICS alone (on the X-axis) versus the MICL in
combination/MICL (on the Y-axis). Based on these isobolograms,
the points above the straight line indicates antagonistic actions;Fig. 1. Isobolograms of S. chamelaeagnea and L. lethose below the line are synergistic actions and those just next to
the lines are additive. Based on the sum FIC values, values b1:
synergistic action; values N1: antagonistic action; and values ≈1:
additive actions.




sum FICSL Sum of the fractional inhibitory concentration of
S. chamelaeagnea and L. leonurus.
MICS Minimum inhibitory concentration of
S. chamelaeagnea.
MICL Minimum inhibitory concentration of
L. leonurus.onurus at various ratios against four pathogens.
Table 2
The sum fractional inhibitory concentration (sumFICSL) values ofS. chamelaeagnea










10:0 1.00 1.00 1.00 1.00
9:1 1.39 1.00 0.99 0.55
8:2 1.10 1.00 0.87 0.50
7:3 1.15 0.67 0.78 0.45
6:4 1.20 1.00 0.68 0.53
5:5 0.83 0.67 0.89 0.35
3:7 0.81 1.00 0.81 0.66
2:8 0.93 1.00 3.74 0.78
1:9 1.45 1.00 0.84 0.75
0:10 1.00 1.00 1.00 1.00
Values b1 denote synergistic effect; values N1 denote antagonistic effect and
values =1 denote additive effect.
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presented in Table 1. The two plants showed good antibacterial
activity against the four pathogenswithMIC values≤3mgmL−1.
Particularly, S. chamelaeagnea was very active against the two
Gram-positive bacteria. In traditional medicine, the two plants are
used against colds, coughs and influenza (Watt and Breyer-
Brandwijk, 1962; van Wyk et al., 2000) and the in vitro study
therefore supports this.
The isobolograms of S. chamelaeagnea and L. leonurus at
different ratios against the four pathogens are shown in Fig. 1.
Synergistic actions were obtained against Gram-positive bacteria
at nearly all ratios. Only the ratio 2:8 showed antagonistic actions
against S. aureus (data points corresponding to 2.50 and 1.24 not
shown; but can be seen in Table 2 as 3.74). Mostly antagonistic or
additive actions were obtained with the Gram-negative bacteria.
However, ratios 5:5, 3:7 and 2:8 showed synergistic actions
against E. coliwhile ratios 7:3 and 5:5 were synergistic againstK.
pneumoniae. This suggests the two plants in combination are
more effective against Gram-positive bacteria than when they are
used separately. A characteristic of traditional medicine that has
remained constant is the use of plant combinations to cure various
diseases (Iwu, 1994). Thus taking advantage of the mixture of
active compounds to produce the desired biological and clinical
effects (Liu, 2005). Most of the phytomedicines are on the drug
market as whole extracts of plants and traditional practitioners
have always believed that synergistic actions are important to
achieve therapeutic efficacy. The results of this combination study
show that S. chamelaeagnea and L. leonurus display synergistic
or antagonistic actions depending on the test organism and the
specific ratio inwhich the extracts are combined.Watt andBreyer-
Brandwijk (1962) reported that the tincture of L. leonurus and
various Salvia species were used against influenza. Boik (2001)
conducted a large number of combination studies using variousEdited by AK Jagernatural substances and the results strongly suggest that when used
in combination, natural substances can produce synergistic
effects. It is thought that phenolic compounds such as flavonoids
may increase the biological activity of other compounds by
synergistic or other mechanisms (Williamson, 2001). Experimen-
tal evidence of synergistic actions between plants was also shown
in a clinical study on the formulation ofChinese herbs used to treat
eczema (Sheehan and Atherton, 1992). The synergistic effects
obtained with the Gram-positive bacteria indicated that the
combination of natural products might be an alternative approach
in the development of new anti-infective drugs. However, one
should note that antagonistic actions could also occur as can be
seen with the Gram-negative bacteria. The positive result
obtained, albeit in vitro, for Gram-positives may justify why
traditional practitioners use the two plants in combination against
microbial infection.
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